<!– Name:DistributionId Value:8844055 –> <!– Name:EnableQuoteCarouselOnPnr Value:False –> <!– Name:IcbCode Value:5557 –> <!– Name:CustomerId Value:1095645 –> <!– Name:HasMediaSnippet Value:false –> <!– Name:AnalyticsTrackingId Value:6d546716-34da-42ea-9562-b9c638bb0e66 –>
NEWARK, Del, May 23, 2023 (GLOBE NEWSWIRE) — As per Future Market Insights (FMI), the global esophageal implant market size is expected to expand from US$ 147.0 million in 2023 to US$ 280.2 million by 2033. Over the next decade (2023 to 2033), global esophageal implant sales are likely to soar at 6.7% CAGR.
Several factors are expected to drive the global market for esophageal implants. These commonly include the increasing prevalence of esophageal illnesses and the growing popularity of minimally invasive procedures.
Similarly, the adoption of esophageal implants will be driven by technological breakthroughs and product innovation. Improved attributes, such as improved biocompatibility, durability, ease of insertion, and patient comfort, tend to increase market share and boost sales.
Find an overview of this market in the Sample report available in PDF format @ https://www.futuremarketinsights.com/reports/sample/rep-gb-17242
Compliance with regulatory requirements and regulatory approvals are required for the commercialization and selling of esophageal implants. Companies that have gotten all of the relevant certifications and approvals have a competitive advantage and better sales.
Reimbursement policies and coverage for esophageal implants have an impact on sales since they affect patients’ access to and affordability of these devices. Favourable reimbursement regulations can boost esophageal implant acceptance and sales.
Because of variances in healthcare infrastructure, disease incidence, economic variables, and cultural factors, demand for esophageal implants varies among areas and countries. Companies may need to adjust their sales strategy to target various regional areas.
Key Takeaways from the Esophageal Implant Market:
- Global sales of esophageal implants are expected to surge at 6.7% CAGR through 2033.
- Based on the product, esophageal stents segment is forecast to progress at 6.0% CAGR from 2023 to 2033.
- By application, the gastroesophageal reflux disease (GERD) segment is poised to exhibit 7.4% CAGR through 2033.
- By end-use, the hospital segment is anticipated to expand at a CAGR of 7.1% over the forecast duration.
- The United States’ esophageal implant market value is likely to reach US$ 105.2 million by 2033.
- The United Kingdom’s esophageal implant industry is estimated to reach a valuation of US$ 14.11 million by 2033.
- Esophageal implant demand in China is expected to increase at 8.6% CAGR through 2033.
- Japan’s market is predicted to reach a valuation of US$ 4.4 million by 2033.
- South Korea’s esophageal implant industry is poised to exhibit a 6.9% CAGR during the forecast period.
“Rising prevalence of esophageal disorders globally will create high demand for esophageal implants during the assessment period. To gain profits, manufacturers should focus on markets with favorable regulatory environments and operational guidelines.” – says a lead analyst at Future Market Insights (FMI)
Talk to our analyst and get the complete information of this report @ https://www.futuremarketinsights.com/ask-question/rep-gb-17242
Who is Winning?
Leading manufacturers of esophageal implants include Boston Scientific, Medtronic, Cook Medical, Taewoong Medical., Micro-Tech (Nanjing) Co., Ltd., Ella-CS, M.I. Tech, Merit Medical, Xlumena Inc., Olympus Corporation, Johnson & Johnson, Apollo Endosurgery, Inc., EndoStim, NDO Surgical, Inc, Mederi Therapeutics, Becton Dickenson & Company, and Baxter International (Synovis Surgical Innovations) among other companies.
These key players are increasingly spending money on research and development activities to develop new products with better features. To fulfill shifting customer needs, they are also focusing on expanding their product line and bolstering their distribution networks.
Tactical alliances and connections with other firms are progressively popular in the sector, permitting participants to utilize one another’s strengths and broaden their influence in the marketplace.
Leading firms also adopt strategies such as mergers, partnerships, acquisitions, and collaborations to strengthen their position in the market and get access to new markets.
- In 2020, Olympus started the commercial launch of the HANAROSTENT Esophagus TTS Stent.
More Insights Available:
Future Market Insights (FMI), in its new offering, presents an unbiased analysis of the esophageal implant market presenting historical data (2017 to 2022) and forecast statistics for the period from 2023 to 2033.
The study reveals future market projections based on the product (esophageal stents, magnetic sphincter augmentation (MSA) devices, injectable bulking agents, and artificial esophageal valves), application (gastroesophageal reflux disease (GERD), esophageal strictures, esophageal fistulas, esophageal defects, and weakened esophageal sphincters), and end-user (hospitals, ambulatory surgical centers, specialty clinics, academic & research institutions, and weakened esophageal sphincters) across various regions.
Esophageal Implant Market Segmentation
- Esophageal Stents
- Self-Expandable Metal Stents (SEMS)
- Polymer Stents
- Biodegradable Stents
- Hybrid Stents
- Magnetic Sphincter Augmentation (MSA) Devices
- Injectable Bulking Agents
- Artificial Esophageal Valves
- Endoscopic Esophageal Valves
- Prosthetic Esophageal Valves
- Gastroesophageal Reflux Disease (GERD)
- Esophageal Strictures
- Esophageal Fistulas
- Esophageal Defects
- Weakened Esophageal Sphincters
By End User:
- Ambulatory Surgical Centers
- Speciality Clinics
- Academic & Research Institutions
- Weakened Esophageal Sphincters
- North America
- Latin America
- East Asia
- South Asia
- The Middle East & Africa
Grow your profit margin – buy this report at a discounted price now @ https://www.futuremarketinsights.com/checkout/17242
Table of Content (ToC):
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Value-Added Insights
4.1. Product Adoption / Usage Analysis
4.2. Product Features/ USP’s
4.3. Technological Roadmap
4.4. Reimbursement Scenario
4.5. Recent Product Approved / Launched
4.6. Regulatory Landscape
4.7. PESTEL Analysis
4.8. Porter’s Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
Complete TOC: https://www.futuremarketinsights.com/toc/rep-gb-17242
About Healthcare Division at Future Market Insights (FMI)
Future Market Insights (FMI) facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you in devising innovation-driven trajectories for your business. Know more about our sector coverage here.
Explore FMI’s Extensive Ongoing Coverage of Healthcare Market Insights
Hearing implant Market Size: The hearing implant market will exhibit a robust 7.31% year-over-year growth in 2021.
Medical Bionic Implant And Artificial Organs Market Share: Global medical bionic implant and artificial organs market demand is anticipated to be valued at US$ 27,953.3 Million in 2022,
Nasal Implant Market Trends: Nasal implant or nose sculpting refers to the augmentation of the nasal bridge or covering the concave deformities in the injured or asymmetrical nose.
Steroid Releasing Implant Market Demand: Steroid Releasing Implant Market: Global Industry Analysis 2012 to 2016 and Opportunity Assessment; 2017 to 2027
Implantable Defibrillator Market Analysis: The implantable defibrillator market size is projected to be valued at US$ 3,652.12 Mn in 2022 and is expected to rise to US$ 6,063.21 Mn by 2032.
Implantable Drug Infusion Pumps Market Outlook: Implantable drug infusion pumps are surgically implanted under the skin.
Implantable Infusion Pump Market Forecast: The global implantable infusion pump market is expected to reach a valuation of US$ 485.1 Million in 2022
Implant-Borne Prosthetics Market Sales: The increased use of Implant-borne prosthetics in dental implants grow rapidly due to the treatment of choice to replace missing teeth in partially edentulous areas.
Implantable Collamer Lens Market Values: The global implantable collamer lens market is expected to reach a valuation of US$ 244.8 Million in 2022.
Dental Implants and Prosthetics Market Growth: Global dental implants and prosthetics market sales were valued at around US$ 11.6 Billion at the end of 2021. The market is projected to register a 7.0% CAGR and top a valuation of US$ 23.7 Billion by 2032.
About Future Market Insights (FMI):
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favour the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10 years.
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
LinkedIn | Twitter | Blogs | YouTube
For Sales Enquiries: [email protected]